Why AstraZeneca Stock Topped the Market on Tuesday
Trading in AstraZeneca‘s (AZN 2.26%) American Depositary Shares (ADSes) was lively on Tuesday, on news that its leadership…
AstraZeneca: Fascinating Company With Lofty Ambitions – Just Not A Buy Yet (NASDAQ:AZN)
This article was written by Follow Edmund Ingham is a biotech consultant. He has been covering biotech, healthcare,…
AstraZeneca Deal Gives Cellectis a $264M Runway
Cellectis Today $1.53 +0.02Â (+1.32%) As of 04/25/2025 04:00 PM Eastern 52-Week Range $1.10 â–¼ $3.38 Price Target $7.00…
Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today
Just like the rest of the stock market, pharmaceutical stocks are in a funk approaching the midweek mark,…
AstraZeneca signs strategic partnership with Beijing; invests $2.5bn
UK and Swedish pharmaceutical giant AstraZeneca is investing $2.5 billion in Beijing to establish its sixth global…
AstraZeneca Aims to Make Cell Therapy More Accessible With $425M EsoBiotec Acquisition
AstraZeneca already has cell therapies in its pipeline, and it is now expanding its scope further with a…
AstraZeneca Secures China Rights to Anemia Drug, Buying FibroGen Unit in $160M Deal
An anemia drug developed under an alliance between FibroGen and AstraZeneca will continue its commercialization in China fully…
What's a Good Price for AstraZeneca Stock?
Healthcare companies are interesting because they are not highly correlated with macroeconomic factors. Where to invest $1,000 right…
How Is The Market Feeling About AstraZeneca? – AstraZeneca (NASDAQ:AZN)
AstraZeneca’s AZN short percent of float has risen 12.24% since its last report. The company recently reported that…
AstraZeneca goes cheap – should you buy?
Shares in pharmaceutical giant AstraZeneca (LSE: AZN) took a hit last month after the head of the company’s…